Polaryx Therapeutics, Inc.

Polaryx Therapeutics (PLYX) has reported zero cyber incidents and zero red-flag 8-K filings over the past 90 days, indicating a clean recent compliance record. However, a 90-day window captures only a snapshot of corporate health; the absence of detected events does not preclude underlying risks in earlier periods or structural vulnerabilities. The full $49 Report extends analysis to 12 months of SEC filings, adds dilution risk scoring, maps financing history and capital structure stress points, and surfaces AI-detected signals that routine screening often misses. The full $49 Report adds comprehensive dilution modeling, 12-month 8-K context, and predictive risk signals beyond the quiet recent quarter.